ifosfamide has been researched along with Renal Insufficiency, Chronic in 9 studies
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Nephrotoxicity is a known side effect of several treatments, including cisplatin, carboplatin, ifosfamide, radiotherapy and nephrectomy, and can cause glomerular filtration rate (GFR) impairment, proteinuria, tubulopathy, and hypertension." | 5.01 | Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer. ( Bökenkamp, A; Kooijmans, EC; Tettero, JM; Tjahjadi, NS; van der Pal, HJ; van Dulmen-den Broeder, E; Veening, MA, 2019) |
| " Nephrotoxicity is one of these known (acute) side effects of several treatments, including cisplatin, carboplatin, ifosfamide, radiotherapy and nephrectomy, and can cause glomerular filtration rate impairment, proteinuria, tubulopathy and hypertension." | 4.89 | Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer. ( Blufpand, H; Bökenkamp, A; Jaspers, MW; Knijnenburg, SL; Kremer, LC; Mulder, RL; Schouten-Van Meeteren, AY; van Dulmen-den Broeder, E; Veening, MA, 2013) |
| "In addition, polyploidy of TEC was observed to correlate with loss of lysozyme staining." | 1.91 | Cellular senescence in kidney biopsies is associated with tubular dysfunction and predicts CKD progression in childhood cancer patients with karyomegalic interstitial nephropathy. ( Broekhuizen, R; Goldschmeding, R; Haveman, LM; Janssens, GO; Keijzer-Veen, MG; Knoppert, SN; Lilien, MR; Nguyen, TQ; Stokman, MF; Valentijn, FA; van den Berg, G; van den Heuvel-Eibrink, MM; van Kempen, S, 2023) |
| "Childhood cancer survivors treated with cisplatin, ifosfamide, or carboplatin are at risk for late kidney and blood pressure (BP) abnormalities." | 1.48 | Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study. ( Harel-Sterling, M; Hessey, E; Huynh, L; McMahon, KR; Pizzi, M; Zappitelli, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Knoppert, SN | 1 |
| Keijzer-Veen, MG | 1 |
| Valentijn, FA | 1 |
| van den Heuvel-Eibrink, MM | 1 |
| Lilien, MR | 1 |
| van den Berg, G | 1 |
| Haveman, LM | 1 |
| Stokman, MF | 1 |
| Janssens, GO | 1 |
| van Kempen, S | 1 |
| Broekhuizen, R | 1 |
| Goldschmeding, R | 1 |
| Nguyen, TQ | 1 |
| Paul, A | 1 |
| Duncan, A | 1 |
| Bacchetta, J | 1 |
| Dubourg, L | 1 |
| Marec-Bérard, P | 1 |
| Tanné, C | 1 |
| McMahon, KR | 1 |
| Harel-Sterling, M | 1 |
| Pizzi, M | 1 |
| Huynh, L | 1 |
| Hessey, E | 1 |
| Zappitelli, M | 1 |
| Kooijmans, EC | 1 |
| Bökenkamp, A | 2 |
| Tjahjadi, NS | 1 |
| Tettero, JM | 1 |
| van Dulmen-den Broeder, E | 2 |
| van der Pal, HJ | 1 |
| Veening, MA | 2 |
| Knijnenburg, SL | 1 |
| Mulder, RL | 1 |
| Schouten-Van Meeteren, AY | 1 |
| Blufpand, H | 1 |
| Kremer, LC | 1 |
| Jaspers, MW | 1 |
| Zubowska, M | 1 |
| Wyka, K | 1 |
| Fendler, W | 1 |
| Młynarski, W | 1 |
| Zalewska-Szewczyk, B | 1 |
| Jaśkowski, P | 1 |
| Krzanowska, K | 1 |
| Miarka, P | 1 |
| Krzanowski, M | 1 |
| Sułowicz, W | 1 |
| Kesik, V | 1 |
| Demirkaya, E | 1 |
| Buyukpamukçu, M | 1 |
| Perazella, MA | 1 |
| Moeckel, GW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia in Pediatric Oncology Patients Treated With Cisplatin-Based Chemotherapy: Randomized Clinical Trial[NCT03449693] | Phase 2 | 214 participants (Anticipated) | Interventional | 2017-10-19 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for ifosfamide and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
Topics: Adult; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Hyp | 2019 |
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Topics: Adult; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Hyp | 2013 |
Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy.
Topics: Acute Kidney Injury; Antineoplastic Agents; Cisplatin; Diphosphonates; Humans; Ifosfamide; Kidney Gl | 2010 |
6 other studies available for ifosfamide and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Cellular senescence in kidney biopsies is associated with tubular dysfunction and predicts CKD progression in childhood cancer patients with karyomegalic interstitial nephropathy.
Topics: Biopsy; Cellular Senescence; Child; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Kidney; | 2023 |
Chronic kidney disease consecutive to chemotherapy for chondroblastic osteosarcoma: A report on 6 pediatric cases.
Topics: Adolescent; Bone Neoplasms; Child; Humans; Ifosfamide; Osteosarcoma; Renal Insufficiency, Chronic; R | 2021 |
Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study.
Topics: Acute Kidney Injury; Antineoplastic Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; C | 2018 |
Interleukin 18 as a marker of chronic nephropathy in children after anticancer treatment.
Topics: Adolescent; Antineoplastic Agents; beta 2-Microglobulin; Biomarkers; Carboplatin; Child; Child, Pres | 2013 |
[Patient receiving peritoneal dialysis after treatment of ovarian cancer].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; If | 2014 |
Urinary neutrophil gelatinase associated lipocalin as a biomarker in ifosfamide induced chronic renal failure.
Topics: Acute-Phase Proteins; Adolescent; Antineoplastic Agents, Alkylating; Biomarkers; Case-Control Studie | 2015 |